Yanagimoto Hiroaki, Satoi Sohei, Yamamoto Tomohisa, Toyokawa Hideyoshi, Hirooka Satoshi, Yui Rintaro, Yamaki So, Ryota Hironori, Inoue Kentaro, Michiura Taku, Matsui Yoichi, Kwon A-Hon
Department of Surgery, Kansai Medical University, Osaka, Japan.
Am Surg. 2014 Jan;80(1):36-42.
The objective of this study was to examine whether the development of cholangitis after preoperative biliary drainage (PBD) can increase the incidence of postoperative pancreatic fistula (POPF). The study population included 185 consecutive patients who underwent pancreaticoduodenectomy from April 2006 to March 2011. All patients were divided into two groups, which consisted of a "no PBD" group (73 patients) and a PBD group (112 patients). Moreover, the PBD group was divided into a "cholangitis" group (21 patients) and a "no cholangitis" group (91 patients). Clinical background, clinical outcome, and postoperative complications were compared between groups. All patients received prophylactic antibiotics using cefmetazole until 1 or 2 days postoperatively. There was no difference between noncholangitis and non-PBD groups except the frequency of overall POPF. Clinically relevant POPF and drain infection occurred in the cholangitis group significantly more than in the noncholangitis group (P < 0.05). Univariate and multivariate analyses showed that development of preoperative cholangitis after preoperative biliary drainage and small pancreatic duct (less than 3 mm diameter) were independent risk factors for clinically relevant POPF. The frequency of clinically relevant POPF was 8 per cent (eight of 99) in patients without two risk factors, 19 per cent (15 of 80) in patients with one risk factor, and 50 per cent (three of six) in patients with both risk factors. The development of preoperative cholangitis after PBD was closely associated with the development of clinically relevant POPF under the limited use of prophylactic antibiotics.
本研究的目的是探讨术前胆道引流(PBD)后胆管炎的发生是否会增加术后胰瘘(POPF)的发生率。研究人群包括2006年4月至2011年3月期间连续接受胰十二指肠切除术的185例患者。所有患者分为两组,即“未行PBD”组(73例患者)和PBD组(112例患者)。此外,PBD组又分为“胆管炎”组(21例患者)和“无胆管炎”组(91例患者)。比较各组之间的临床背景、临床结局和术后并发症。所有患者术后使用头孢美唑预防性抗生素1或2天。除总体POPF发生率外,非胆管炎组和未行PBD组之间无差异。胆管炎组临床相关POPF和引流感染的发生率明显高于非胆管炎组(P<0.05)。单因素和多因素分析显示,术前胆道引流后术前胆管炎的发生和小胰管(直径小于3mm)是临床相关POPF的独立危险因素。无两个危险因素的患者临床相关POPF的发生率为8%(99例中的8例),有一个危险因素的患者为19%(80例中的15例),有两个危险因素的患者为50%(6例中的3例)。在预防性抗生素使用有限的情况下,PBD后术前胆管炎的发生与临床相关POPF的发生密切相关。